One prominent difference between the photosystem II (PSII) reaction center protein D1' in Synechocystis 6803 and normal D1 is the replacement of Phe-186 in D1 with leucine in D1'. Mutants of Synechocystis 6803 producing only D1', or containing engineered D1 proteins with Phe-186 substitutions, were analyzed by 77 K fluorescence emission spectra, chlorophyll a fluorescence induction yield and decay kinetics, and flash-induced oxygen evolution. Compared to D1-containing PSII centers, D1' centers exhibited a 50% reduction in variable chlorophyll a fluorescence yield, while the flash-induced O(2) evolution pattern was unaffected. In the F186 mutants, both the P680(+)/Q(A)(-) recombination and O(2) oscillation pattern were noticeably perturbed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0014-5793(01)02794-6 | DOI Listing |
Nat Prod Res
January 2025
Guangdong Provincial Engineering Research Center for Modernization of TCM, NMPA Key Laboratory for Quality Evaluation of TCM, College of Pharmacy, Jinan University, Guangzhou, China.
Four novel arecoline alkaloid atropisomers, arechuines A-D (-), were obtained from the peels of L. Their structures were elucidated by UV, IR, MS and NMR spectra. The absolute configurations of (+)/(-)- were determined by comparing the experimental and calculated ECD spectra.
View Article and Find Full Text PDFJ Neuropsychol
January 2025
Department of Health, Medical and Neuropsychology, Leiden University, Leiden, The Netherlands.
Up to 45% of patients with Parkinson's disease (PD) experience impulse control disorders (ICDs), characterized by a loss of voluntary control over impulses, drives or temptations. This study aimed to investigate whether previously identified genetic and psychiatric risk factors interact towards the development of ICDs in PD. A total of 278 de novo PD patients (ICD-free at enrollment) were selected from the Parkinson's Progression Markers Initiative database.
View Article and Find Full Text PDFAllergy Asthma Clin Immunol
January 2025
Allergy Research Unit, Kingston Health Sciences Center - KGH Site, Kingston, ON, Canada.
Cell Div
January 2025
Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, 550004, China.
Objective: This study aimed to investigate the regulatory effects of long non-coding RNA-ANRIL on CDKN2A in the cell cycle of Kasumi-1 cells and elucidate the underlying molecular mechanisms.
Methods: ANRIL and CDKN2A expression levels were quantified using RT-qPCR in peripheral blood samples from acute myeloid leukemia (AML) patients. CDKN2A knockdown efficiency was validated via RT-qPCR, and cell cycle distribution was analyzed using flow cytometry.
BMC Public Health
January 2025
Advanced Wellbeing Research Centre, Sheffield Hallam University, Sheffield, UK.
Background: Workplace health screening rarely includes measures of cardiorespiratory fitness, despite it being a greater predictor of cardiovascular disease and all-cause mortality than other routinely measured risk factors. This study aimed to determine the comparative acceptability of using a novel seismocardiography device to measure cardiorespiratory fitness via VO max during a workplace health check.
Methods: Participants were invited to participate in workplace health screening sessions where VO max was assessed by both seismocardiography at rest and sub-maximal exercise testing, in order for acceptability of both to be compared across multiple domains.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!